Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
Journal of Clinical Oncology · 2025-11 · 43 (31) · 3369-3380
DOI: 10.1200/jco-25-00206 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, 2025-11. Verfasst von Stephanie J Lee und 24 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Center, Seattle, WA. Hauptthemen laut MEDLINE: Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Unrelated Donors. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE The likelihood of finding a human leukocyte antigen (HLA)–matched unrelated donor (MUD) for hematopoietic cell transplantation can be predicted using a donor search prognosis score. Patients without a MUD may use alternative donors (haploidentical related, mismatched unrelated, or umbilical cord blood). METHODS This multicenter biological assignment trial was conducted by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1702). Eligibility criteria were broad to mirror clinical practice. The primary end point was 2-year survival from evaluability and compared between those Very Likely (>90%) and Very Unlikely (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fred Hutchinson Cancer Center, Seattle, WA.
- Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
- Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI.
- NMDP, Minneapolis, MN.
- H. Lee Moffitt Cancer Center, Tampa, FL.
- Levine Cancer Institute Atrium Health, Charlotte, NC.
ORCID-Profile: Stephanie J Lee, Brent Logan, Mary M Horowitz, Jason G Dehn, Michael R Grunwald, Nosha Farhadfar, Brandon Hayes-Lattin, LaQuisa Hill, Claudio Brunstein, Mark Juckett, Steven Devine, Bronwen E Shaw, Stefan O Ciurea
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
Zitieren
APA
Lee, S. J., Logan, B., Horowitz, M. M., Dehn, J. G., Pidala, J., Grunwald, M. R., Westervelt, P., Farhadfar, N., Hogan, W. J., Bashey, A., Hayes-Lattin, B., Hill, L., Brunstein, C., Arai, S., Srour, S. A., Symons, H., Uberti, J., Vasu, S., Pusic, I., …, & Ciurea, S. O. (2025). Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation. Journal of Clinical Oncology, 43(31), 3369-3380. https://doi.org/10.1200/jco-25-00206
Vancouver
Lee SJ, Logan B, Horowitz MM, Dehn JG, Pidala J, Grunwald MR, et al. Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation. Journal of Clinical Oncology. 2025;43(31):3369-3380. doi:10.1200/jco-25-00206
BibTeX
@article{Lee2025,
author = {Lee, Stephanie J and Logan, Brent and Horowitz, Mary M and Dehn, Jason G and Pidala, Joseph and Grunwald, Michael R and Westervelt, Peter and Farhadfar, Nosha and Hogan, William J and Bashey, Asad and Hayes-Lattin, Brandon and Hill, LaQuisa and Brunstein, Claudio and Arai, Sally and Srour, Samer A and Symons, Heather and Uberti, Joseph and Vasu, Sumithira and Pusic, Iskra and Juckett, Mark and Leifer, Eric and He, Naya and Devine, Steven and Shaw, Bronwen E and Ciurea, Stefan O},
title = {Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation},
journal = {Journal of Clinical Oncology},
year = {2025},
volume = {43},
number = {31},
pages = {3369--3380},
doi = {10.1200/jco-25-00206}
}
EUVIMED